Filtration markers may have prognostic value independent of glomerular filtration rate.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMC 3269188)

Published in J Am Soc Nephrol on December 15, 2011

Authors

Navdeep Tangri1, Lesley A Inker, Hocine Tighiouart, Eric Sorensen, Vandana Menon, Gerald Beck, Michael Shlipak, Josef Coresh, Andrew S Levey, Mark J Sarnak

Author Affiliations

1: Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA.

Articles citing this

Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int (2013) 1.66

GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD. Am J Kidney Dis (2015) 1.64

Genome-wide significant locus of beta-trace protein, a novel kidney function biomarker, identified in European and African Americans. Nephrol Dial Transplant (2013) 1.56

Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population. Clin J Am Soc Nephrol (2013) 1.11

Update on cystatin C: incorporation into clinical practice. Am J Kidney Dis (2013) 1.06

Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults. Am J Kidney Dis (2013) 1.05

Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes. Am J Kidney Dis (2015) 0.98

Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy. Am J Kidney Dis (2013) 0.92

Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2016) 0.88

Factors other than the glomerular filtration rate that determine the serum beta-2-microglobulin level. PLoS One (2013) 0.87

Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study. PLoS One (2013) 0.86

Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD. Am J Kidney Dis (2016) 0.85

Change in Measured GFR Versus eGFR and CKD Outcomes. J Am Soc Nephrol (2015) 0.83

Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc (2014) 0.81

Laboratory test surveillance following acute kidney injury. PLoS One (2014) 0.81

Beta-2 microglobulin-based equation for estimating glomerular filtration rates in Japanese children and adolescents. Clin Exp Nephrol (2014) 0.80

Comparison of two creatinine-based estimating equations in predicting all-cause and cardiovascular mortality in patients with type 2 diabetes. Diabetes Care (2012) 0.79

Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis. Clin J Am Soc Nephrol (2016) 0.79

Removal and rebound kinetics of cystatin C in high-flux hemodialysis and hemodiafiltration. Clin J Am Soc Nephrol (2014) 0.78

Estimated glomerular filtration rate -a more stable indicator than creatinine clearance in peritoneal dialysis practice. J Rural Med (2013) 0.77

Racial Disparities in Creatinine-based Kidney Function Estimates Among HIV-infected Adults. Ethn Dis (2016) 0.76

Cardiovascular Phenotypes in Children with CKD: The 4C Study. Clin J Am Soc Nephrol (2016) 0.75

Effect of glycemic index and carbohydrate intake on kidney function in healthy adults. BMC Nephrol (2016) 0.75

Chronic kidney disease: Cystatin-C-based eGFR: what is it telling us? Nat Rev Nephrol (2013) 0.75

Relationships of Measured Iohexol GFR and Estimated GFR With CKD-Related Biomarkers in Children and Adolescents. Am J Kidney Dis (2017) 0.75

Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. J Am Heart Assoc (2017) 0.75

Cystatin C as a predictor of cardiovascular outcomes in a hypertensive population. J Hum Hypertens (2017) 0.75

Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial. Am J Transplant (2017) 0.75

Articles cited by this

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33

Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27

Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04

The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med (1994) 11.65

Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32

Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90

Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57

Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis (2011) 2.98

Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis (2010) 2.83

Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int (2003) 2.77

Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71

Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 2.55

Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol (2011) 2.25

Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children. Clin Chem (2002) 2.17

Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol (1993) 1.99

Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study. Circulation (2010) 1.97

Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. Clin Chem (2010) 1.95

Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int (2010) 1.88

A novel equation to estimate glomerular filtration rate using beta-trace protein. Clin Chem (2007) 1.85

beta-Trace protein is an alternative marker for glomerular filtration rate in renal transplantation patients. Clin Chem (2005) 1.71

Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl (1989) 1.66

Low-molecular weight proteins as markers for glomerular filtration rate. Clin Chem (2001) 1.50

Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. Clin Chem (1999) 1.49

Markers for survival in dialysis: a seven-year prospective study. Am J Kidney Dis (1995) 1.22

Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci U S A (1997) 1.17

Estimating GFR using serum beta trace protein: accuracy and validation in kidney transplant and pediatric populations. Kidney Int (2009) 1.14

Serum levels of beta-trace protein and glomerular filtration rate--preliminary results. J Pharm Biomed Anal (2003) 1.02

Prostaglandin D synthase (beta-trace) in healthy human sleep. Sleep (2004) 0.99

Effect of clinical variables and immunosuppression on serum cystatin C and beta-trace protein in kidney transplant recipients. Am J Kidney Dis (2009) 0.96

Serum levels of beta-trace protein and its association to diuresis in haemodialysis patients. Nephrol Dial Transplant (2007) 0.94

Predictive values of beta-trace protein (prostaglandin D synthase) by use of laser-nephelometry assay for the identification of cerebrospinal fluid. Neurosurgery (2002) 0.94

β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure. J Am Coll Cardiol (2011) 0.93

Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years. Am J Kidney Dis (1996) 0.83

Beta-trace protein as indicator of glomerular filtration rate. Urology (1999) 0.83

Beta-trace protein (prostaglandin D synthase)--a stable and reliable protein in perilymph. Ger Med Sci (2005) 0.82

Measuring glomerular filtration rate with cystatin C and beta-trace protein in children with spina bifida. J Urol (2003) 0.81

Expression of functional prostaglandin D (DP) receptors in human corpus cavernosum smooth muscle. Int J Impot Res (2002) 0.81

Biochemical markers of cerebrovascular injury in sleep apnoea syndrome. Eur Respir J (2002) 0.80

Estimation of glomerular filtration rate by use of beta-trace protein. Clin Chem (2008) 0.80

Articles by these authors

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33

Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation (2003) 15.79

Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00

Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2005) 10.42

MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25

Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93

Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98

Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86

International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol (2006) 7.51

Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet (2008) 7.31

Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20

Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med (2006) 6.58

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension (2003) 6.01

Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00

Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89

Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol (2008) 5.70

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45

Chronic kidney disease. Lancet (2011) 5.42

The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10

Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06

Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03

Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78

Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation (2011) 4.78

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75

Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med (2007) 4.58

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA (2004) 4.54

Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med (2007) 4.43

Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34

Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis (2009) 4.30

Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28

An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med (2006) 4.23

A predictive model for progression of chronic kidney disease to kidney failure. JAMA (2011) 4.22

Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet (2009) 4.10

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

Fat distribution in men with HIV infection. J Acquir Immune Defic Syndr (2005) 4.02

Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med (2014) 4.00

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation (2004) 3.96

Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol (2012) 3.91

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87